Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/17/25
End: 04/18/28
Due: 04/18/29
Phase: N/A
Priority: Normal
Start: 10/24/24
End: 02/13/27
Due: 02/13/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of DM002 in Patients With Advanced Solid Tumors | NCT06751329 | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | user2@example.com | None | 2025-02-17 | 2028-04-18 | 2029-04-18 | - | - | 2025-07-14 |
| A Study of DM001 in Patients With Advanced Solid Tumors | NCT06475937 | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | user2@example.com | None | 2024-10-24 | 2027-02-13 | 2028-02-13 | - | - | 2025-07-14 |